|
1.
|
Welsch PL and King MC: BRCA1 and BRCA2 and
the genetics of breast and ovarian cancer. Hum Mol Genet.
10:705–713. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Wideroff L, Vadaparampil ST, Greene MH,
Taplin S, Olson L and Freedman AN: Hereditary breast/ovarian and
colorectal cancer genetics knowledge in a national sample of US
physicians. J Med Genet. 42:749–755. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Evans DG, Shenton A, Woodward E, Lalloo F,
Howell A and Maher ER: Penetrance estimates for BRCA1 and BRCA2
based on genetic testing in a Clinical Cancer Genetics service
setting: risks of breast/ovarian cancer quoted should reflect the
cancer burden in the family. BMC Cancer. 8:1552008. View Article : Google Scholar
|
|
4.
|
Barnes DR and Antoniou AC: Unravelling
modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2
mutation carriers: update on genetic modifiers. J Int Med.
271:331–343. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Tang LL, Chen FY, Wang H, et al: Haplotype
analysis of eight genes of the monoubiquitinated FANCD2-DNA
damage-repair pathway in breast cancer patients. Cancer Epidemiol.
37:311–317. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Fanale D, Amodeo V, Corsini LR, Rizzo S,
Bazan V and Russo A: Breast cancer genome-wide association studies:
there is strength in numbers. Oncogene. 31:2121–2128. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Chatterjee A, Mambo E and Sidransky D:
Mitochondrial DNA mutations in human cancer. Oncogene.
25:4663–4674. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Imanishi H, Hattori K, Wada R, et al:
Mitochondrial DNA mutations regulate metastasis of human breast
cancer cells. PLoS One. 6:e234012011. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Martinez-Outschoorn UE, Lin Z, Trimmer C,
Flomenberg N and Wang C: Cancer cells metabolically ‘fertilize’ the
tumor microenvironment with hydrogen peroxide, driving the Warburg
effect: implications for PET imaging of human tumors. Cell Cycle.
10:2504–2520. 2011.
|
|
10.
|
Akouchekian M, Houshmand M, Akbari MH,
Kamalidehghan B and Dehghan M: Analysis of mitochondrial ND1 gene
in human colorectal cancer. J Res Med Sci. 16:50–55.
2011.PubMed/NCBI
|
|
11.
|
Ding C, Li R, Wang P, Jin P, Li S and Guo
Z: Identification of sequence polymorphisms in the D-Loop region of
mitochondrial DNA as a risk factor for lung cancer. Mitochondrial
DNA. 23:251–254. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Fendt L, Niederstätter H and Huber G:
Accumulation of mutations over the entire mitochondrial genome of
breast cancer cells obtained by tissue microdissection. Breast
Cancer Res Treat. 128:327–336. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Sultana GN, Rahman A, Shahinuzzaman AD,
Begum RA and Hossain CF: Mitochondrial DNA mutations - candidate
biomarkers for breast cancer diagnosis. Chin J Cancer. 31:449–454.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Taanman JW: The mitochondrial genome:
structure, transcription, translation and replication. Biochim
Biophys Acta. 1410:103–123. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Suzuki M, Toyooka S, Miyajima K, Iizasa T,
Fujisawa T, Bekele NB and Gazdar AF: Alterations in the
mitochondrial displacement Loop in lung cancers. Clin Cancer Res.
9:5636–5641. 2003.PubMed/NCBI
|
|
16.
|
van Oven M and Kayser M: Updated
comprehensive phylogenetic tree of global human mitochondrial DNA
variation. Hum Mutat. 30:E386–E394. 2009.PubMed/NCBI
|
|
17.
|
Torroni A, Achilli A, Macaulay V, Richards
M and Bandelt HJ: Harvesting the fruit of the human mtDNA tree.
Trends Genet. 22:339–345. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Underhill PA and Kivisild T: Use of y
chromosome and mitochondrial DNA population structure in tracing
human migrations. Annu Rev Genet. 41:539–564. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Bai RK, Leal SM, Covarrubias D, Liu A and
Wong LJ: Mitochondrial genetic background modifies breast cancer
risk. Cancer Res. 67:4687–4894. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Fang H, Shen L, Chen T, He J and Ding Z:
Cancer type-specific modulation of mitochondrial haplogroups in
breast, colorectal and thyroid cancer. BMC Cancer. 10:4212010.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Tommasi S, Crapolicchio A, Lacalamita R,
Bruno M and Monaco A: BRCA1 mutations and polymorphisms in a
hospital-based consecutive series of breast cancer patients from
Apulia, Italy. Mutat Res. 578:395–405. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Gasparre G, Romeo G, Rugolo M and Porcelli
AM: Learning from oncocytic tumors: Why choose inefficient
mitochondria? Biochim Biophys Acta. 1807:633–642. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Peng Z, Xie C, Wan Q, Zhang L, Li W and Wu
S: Sequence variations of mitochondrial DNA D-Loop region are
associated with familial nasopharyngeal carcinoma. Mitochondrion.
11:327–333. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Liu VW, Shi HH, Cheung AN, et al: High
incidence of somatic mitochondrial DNA mutations in human ovarian
carcinomas. Cancer Res. 61:5998–6001. 2001.PubMed/NCBI
|
|
25.
|
Liu VW, Yang HJ, Wang Y, et al: High
frequency of mitochondrial genome instability in human endometrial
carcinomas. Br J Cancer. 89:697–701. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Pham XH, Farge G, Shi Y, Gaspari M,
Gustafsson CM and Falkenberg M: Conserved sequence box II directs
transcription termination and primer formation in mitochondria. J
Biol Chem. 281:24647–24652. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Lin CS, Wang LS, Chang SC, Chou TY and Hsu
WH: Associated microsatellite alterations in mitochondrial DNA and
in TP53 in thoracic esophageal squamous cell carcinoma. Oncol Rep.
28:69–76. 2012.PubMed/NCBI
|
|
28.
|
Alhomidi MA, Vedicherla B, Movva S, Rao
PK, Ahuja YR and Hasan Q: Mitochondrial D310 instability in Asian
Indian breast cancer patients. Tumour Biol. 34:2427–2732. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Troudi W, Loueslati B, Baccar A, Ben Ayed
F, Ben Ammar El and Gaaied A: Penetrance of BRCA1 gene mutation and
DNA mitochondrial in Tunisian breast cancer occurrence. Tunis Med.
87:494–498. 2009.(In French).
|
|
30.
|
Ma Y, Bai RK, Trieu R and Wong LJ:
Mitochondrial dysfunction in human breast cancer cells and their
transmitochondrial cybrids. Biochim Biophys Acta. 1797:29–37. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Hossein R and Houshmand M: Diagnostic
algorithm for identification of individuals with hereditary
predisposition to breast cancer. Lik Sprava. 1–2:103–108.
2008.PubMed/NCBI
|
|
32.
|
Fernandez-Silva P, Enriquez JA and Montoya
J: Replication and transcription of mammalian mitochondrial DNA.
Exp Physiol. 88:41–56. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Ebner S, Lang R, Mueller EE, Eder W,
Oeller M, et al: Mitochondrial haplogroups, control region
polymorphisms and malignant melanoma: a study in middle European
Caucasians. PLoS One. 6:e271922011. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Czarnecka AM, Krawczyk T, Plak K, et al:
Mitochondrial genotype and breast cancer predisposition. Oncol Rep.
24:1521–1534. 2010.PubMed/NCBI
|
|
35.
|
Torroni A, Huoponen K, Francalacci P,
Petrozzi M and Morelli L: Classification of European mtDNAs from an
analysis of three European populations. Genetics. 144:1835–1850.
1996.PubMed/NCBI
|
|
36.
|
Torroni A, Richards M, Macaulay V, Forster
P and Villems R: mtDNA haplogroups and frequency patterns in
Europe. Am J Hum Genet. 66:1173–1177. 2000. View Article : Google Scholar : PubMed/NCBI
|
